Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):471. doi: 10.1136/jnnp-2013-306043. Epub 2013 Sep 27.
No abstract available

Keywords: ENDOCRINOLOGY; PHARMACOLOGY; PSYCHOLOGY.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminoquinolines / adverse effects*
  • Dopamine Agonists / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Prolactinoma / complications*
  • Prolactinoma / drug therapy
  • Substance Withdrawal Syndrome / diagnosis*

Substances

  • Aminoquinolines
  • Dopamine Agonists
  • quinagolide